Market Research Logo

Human Biobanking Applications - Global Trends, Estimates And Forecasts, 2014-2020 - Report Focus

Human Biobanking Applications - Global Trends, Estimates And Forecasts, 2014-2020 - Report Focus

The report “Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:-

Emerging Market Trends
Advancements in the Technological Space
Market Demand Of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking applications market. Further, the subdivided categories include:
1. Stem Cells
2. Blood1 & Blood Products
3. Organs2
4. Advanced Applications
a. Biomarkers
b. Genomics3
c. Drug Discovery
d. Forensics
5. Research
6. Pharmaceuticals
7. Other4

The period considered for the human biobanking applications market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.


I. REPORT FOCUS
A. INTRODUCTION
BIOREPOSITORY
CLASSIFYING BIOBANKS
STORING SAMPLES IN A BIOBANK
BIOSPECIMEN SECURITY AND STORAGE
THE GENERATIONAL EVOLUTION OF BIOBANK
PUTTING TOGETHER A BIO BANK WITH ITS REQUIREMENTS AND CAPACITIES
TECHNICAL REQUIREMENTS
FUNCTIONAL REQUIREMENTS
BIOREPOSITORY OPERATIONS
GETTING A BIOREPOSITORY ACCREDITED
THE ROLE OF SYNTHETIC DATA IN BIOBANK ANALYSIS
B. BIOBANKING BENEFITS
CONCLUSION
C. BIOSPECIMENS (COLLECTION, PROCESSING, STORAGE,
RETRIEVAL AND DISSEMINATE)
BIOSPECIMENS IN CANCER RESEARCH
BIOSPECIMENS - THE LEGACY PLAN
DECADES OLD SPECIMENS MAY BE TODAY’S RESEARCH TREASURES
BIOSPECIMEN MANAGEMENT SYSTEM
THE MODERN APPROACH TO BIOBANKING
ISOLATING STOMACH-CELL POPULATIONS USING LCM
RESULTS FROM THE BPV PROGRAM
EVALUATION OF PRE-ANALYTICAL FACTORS ON IDENTIFICATION
OF COPY NUMBER VARIATIONS
THE IMPACT OF EX-VIVO ISCHEMIA TIME ON QUALITY OF RNA
THE IDEAL PHYSICAL ENVIRONMENT FOR BIOSPECIMENS
CASE STUDY: ADVANCED IT SYSTEM FOR RESEARCH BIOREPOSITORY
PHYSICAL PHENOMENON AT LOW TEMPERATURES
BIOLOGICAL PHENOMENON AT LOW TEMPERATURES
STORAGE METHODS FOR VARIOUS BIOSPECIMENS
1. STORING PROTEINS AND PURIFIED NUCLEIC ACIDS
2. STORING CRYO-PRESERVED CELLS
3. STORING TISSUES
CONCLUSION
1. COMPILATION OF STUDIES DESCRIBING THE STABILITY OF SPECIFIC BIOMARKERS FOR BIOSPECIMENS
(BIOFLUIDS, CELLS, TISSUES) AS A FUNCTION OF STORAGE TEMPERATURE/DURATION
TRANSPORTING BIOSPECIMENS
EFFECTS OF TRANSPORTATION ON MONONUCLEAR CELLS
FINDING BIO-SAMPLES
OUT OF THE COLD-DRY STATE
BANKING ON SUCCESS FOR PRECISION MEDICINE
THE CLOSE OF THE ULTIMATE PERIOD IN BIO-BANKING
COST OF VALUE STUDY: RELATE THE THEORY TO BIOBANKS
MALFUNCTION COSTS:
EXTERNAL STOPPAGE COSTS:
BIOBANK ECONOMIC MODELING TOOL: A COST IMPROVEMENT DEVICE
FOR CONTINUITY OF BIO-BANKS
INSTITUTION OF AN ISO15189 ACCREDITED BIO-BANK
FOR GLOBAL CLINICAL RESEARCH STUDIES
CRITICAL MOVES TO BUILD BIO-BANKS: STAGE WISE PROCESS
FOR LOW INCOME NATIONS
THE INSTITUTION OF A BIO-BANK AND COHORT NETWORK (BCNET)
FOR LOW AND MIDDLE INCOME COUNTRIES
BIO-BANKING AND TRANSLATIONAL MEDICINE: THE SCHOLARLY OUTLOOK
A WORKABLE METHODOLOGY DEVISED BY BIO-BANK GRAZ: A REPRESENTATION
FOR OTHER UNIVERSITY-BASED INSTITUTIONS
THE SUSTAINABILITY ISSUE OF A COMMUNITY HOSPITAL-BASED BIO-BANK
AND CORE MOLECULAR LABORATORY: THE BEAUMONT UNDERSTANDING
TO MAINTAIN A DISEASE CENTERED BIO-BANKING - AN ACTIVE APPROACH
D. BIOBANKING PRINCIPLES
NORMS BASED ON INTERFACE COMPREHENSION
DATA STANDARDS ARE NOT MAXIMIZED IN RESEARCH BIO-BANKING
DATA STANDARDS - PROPOSED BY OBBR AND ISBER
DATA STANDARDS PROGRAM FOR BIO-BANKS
DESIGN OF A REGISTRY OF STANDARD OPERATING PROTOCOLS
FOR TISSUE COMPILATION
E. PATH BREAKING TECHNOLOGIES
THE BIO-BANK INFORMATION MANAGEMENT SYSTEM LIFE CYCLE ORGANIZATION
AND THE BIMS CLOUD MANAGEMENT PLATFORM
AMALGAMATION OF STANDARD PRE-ANALYTICAL CODE WITH
BIO-BANK ORGANIZATION SOFTWARE FREEZER PRO
EVALUATION OF COMPUTERIZATION TECHNOLOGIES AND PHYSICAL STORAGE
AND RECOVERY
FUTURE OUTLOOK AND CONCERNS IN THE SETUP OF SOFTWARE SOLUTIONS
IN AN INTERDISCIPLINARY CLINICAL BIOBANK
A MECHANICAL LABORATORY WORKFLOW FOR STOOL DNA REMOVAL
CONSISTENT WORKFLOW FOR BIO-MATERIAL APPEALS
PARTIALLY COMPUTERIZED BIO-BANK SAMPLE PROCESSING WITH A 384 HIGH DENSITY
SAMPLE TUBE ROBOT DEPLOYED IN CANCER AND CARDIOVASCULAR RESEARCH
AN AUTONOMOUS APPRAISAL OF THE CRYOXTRACT CXT350 FROZEN BIO-SPECIMEN
CORING APPLICATION WITH TISSUE AND STOOL FECAL SAMPLES
HEAT STANDARDIZATION OF TISSUE SAMPLES SUPPORTS MEASUREMENT WITHOUT
INTRUSION FROM POST-MORTEM OCCURRENCES AND PERMITS FOR REFINEMENT
BECAUSE OF MINIMIZED INTRA GROUP VARIABILITY
BIOT CRYOCARRIER - STANDARDIZED CRYOGENIC TEMPERATURE HANDLING OF
BIOSPECIMENS
PROTECTION BY VAPORIZATION FOR BIO-BANKING
OPTIMUM SPECIMEN SECURITY WITH COMPLETE AUTOMATION CHARACTERISTICS:
THE AUTOMATED LN2 VAPOUR PHASE FREEZER
EXERCISE OF ELECTRONIC P-CHIPS IN A MONO AND DUOTAGGING SYSTEM
FOR SAMPLE TUBES USED IN BIO-BANKING
SAMPLE TRAIL AND PREREQUISITE WITH IPLEX® PRO SAMPLE ID
USAGE OF AN E-CONSENT SYSTEM FOR BIO-BANK PATIENT CONSENT
– THE THREE WHYS
CELL LINE VERIFICATION WITH THE USE OF SNP TRACE™ PANEL:
A HIGH-THROUGHPUT, AFFORDABLE SNPBASED INTERFACE FOR FINGERPRINTING,
IDENTIFYING INFECTIVITY, AND ESTABLISH ORIGIN OF DERIVATIVE CELL LINES
NEXT-GENERATION DNA SEQUENCING WITH SUSTAINED
PRESERVED SERUM SAMPLES
AN ASSESSMENT OF FROZEN ALIQUOTTING APPLICATION FOR THE STABILIZATION
OF SMALL MOLECULE AND PEPTIDES IN BIO-ANALYTICAL TECHNOLOGY
F. BIOBANKING PERFORMANCES
PERFORMANCES INSIDE THE BIO-BANK
ETHICAL, LEGAL AND APPROPRIATE STRATEGIES
SOCIETAL COMMITMENT FOR GROWTH OF CDC POLICY LEADING SUPERVISION
OF SPECIMENS ATTAINED FROM AMERICAN INDIAN/ALASKA NATIVE PEOPLE
LEGAL AND REGULATORY HURDLES THAT IMPACT COMPLETION OF
AN INTER-INSTITUTIONAL BIO-BANK SYSTEM
IN –DEPTH APPRAISAL ON BIO-BANKING PERFORMANCES
SPECIMEN RESEARCH
SAFEGUARD AND CONTROL SAMPLE DATA
BIO-SAMPLES PRESERVATION AND SAFETY PRECAUTIONS
MONITOR SAMPLES THROUGH TRANSPORT
FARM OUT SAMPLES
CONCLUSION
G. BIOBANK APPLICATIONS
STEM CELLS
FUNDAMENTAL FEATURES IN SETTING UP A STEM CELL-SPECIFIC BANK
SAFEGUARDS TO FUTURE HEALTH VIA CORD BLOOD AND CORD TISSUE STEM CELLS
SAFEGUARD ONES HEALTH FOR YEARS TO COME
BLOOD AND ITS COMPONENTS
RED BLOOD CORPUSCLES
PLASMA
BLOOD PLATELETS
TYPES OF BIOBANKS
ORGAN AND TISSUE BIOBANK FOR THERAPY AND TRANSPLANTATION
GENETIC BIOBANKS
POPULATION BIOBANK
SOME COMMON OBJECTIVES OF BIOBANKS:
THERAPY FOR THE MOST PREVALENT GENETIC DISORDERS
PHARMACEUTICALS
CUSTOMIZED DRUGS
EXPANSION OF NOVEL DRUGS
RESEARCH
STEM CELLS
A BIOBANK’S IMPACT: ACHIEVING TRANSLATION MEDICINE IN CANCER RESEARCH
EFFECTS OF A BIOBANK ON CLINICAL RESEARCH
BIOBANK INVESTIGATIONS ADVANTAGES
H. BIOBANK - ADVANCED APPLICATIONS
CURRENT ROLE OF BIO-BANKING IN MEDICAL ENVIRONMENT
A CASE FOR OUTSOURCING
A BIOMATERIAL STORAGE PROVIDER
COLD-CHAIN MANAGEMENT, TRACKING AND MONITORING
BRAIN BANK
EXTRACTING A BRAIN
FIXATION ALTERNATIVES FOR RNA PRESERVATION
COMPARISON OF THE FLUIDIGM SNP TRACE™ PANEL AND DNAQUAL
THE CONNECTION BETWEEN CARDIAC TRANSPLANTATION AND BIOBANKS
GENTYPE-TISSUE EXPRESSION
FACTORS AFFECTING STORAGE OF BIOLOGICAL TISSUES
2. STORAGE TIME, NUMBER, TYPE OF SAMPLE AND AVERAGE RIN VALUES
LONG-TERM STORAGE OF DNA: OLD AND NEW METHODS
3. DNA SAMPLES AND THEIR SOURCE
CONCLUSION
I. CANCER BIOBANKING
THE ROLE OF BIOBANKS IN CANCER RESEARCH
BIOBANKS: THE BENCHMARKS
4. A LIST OF POSSIBLE PRE-ANALYTICAL VARIABLES THAT COULD AFFECT SAMPLES IN A CANCER BIOBANK
CASE STUDY: JANUS SERUM BANK
INFORMED CONSENT AMONGST DISADVANTAGED COMMUNITIES
FOR BIOBANK RESEARCH
ENHANCING COLLECTION METHODS AT THE UCCITB
THE ROLE OF THE CCGC IN CANCER RESEARCH IN CHINA
THE PCBN:
PROSTATE CANCER
OVERVIEW
PROSTATE CANCER BIOBANKING: COLLECTION METHODS
AND EVALUATION TECHNIQUES
A PROSTATE CANCER BIOREPOSITORY TO SATISFY INTERNATIONAL
COLLABORATIVE DEMANDS
PROCURE PROSTATE CANCER BIOBANK
MIRROR IMAGE METHOD: A NEW TECHNIQUE FOR HISTOLOGICAL
ASSESSMENT OF TUMOR SAMPLES
NEW CONSENTING PROGRAMS IN THE WCB
NEXT-GENERATION CANCER BIOBANKING: SEQUENCING AND
PERSONALIZED MEDICINE
WHAT ARE SUSTAINABILITY METRICS IN A CANCER-ORIENTED BIOBANK?
ESTIMATING BIOBANK INVENTORY REQUIREMENTS
PLATFORMS TO SCREEN NEW CANCER-INHIBITING DRUGS
THE DEVELOPMENT OF NEW TECHNIQUES TO PERFORM DOWNSTREAM ANALYSIS
OF IMMUNO-STAINED FFPE SLIDES
A BIOBANK’S ECONOMIC DRIVERS
THE ROLE OF STANDARDIZED PROCEDURES IN BIOBANK MANAGEMENT
DECREASING RESEARCH COSTS
ENHANCING PATIENT CARE AT LOWER COSTS
BIOBANKS AND CANCER EVOLUTION
BIOBANK TRENDS
BIOMARKERS
THE RELATION BETWEEN BIOMARKERS AND BIOBANKS
MAXIMIZING CHANCES OF BIOMARKER IDENTIFICATION
THE EFFECT OF PRE-ANALYTICAL VARIABLES ON TISSUES
EXAMPLES OF BIOMARKER IDENTIFICATION
IMMUNE CELLS AS BIOMARKERS FOR EXPOSURE TO IONIZING RADIATION:
FROZEN TISSUE-CORE ANALYSIS
STORAGE STABILITY OF CYTOKINE DIABETES BIOMARKERS
FORENSICS
DRUG BREAKTHROUGHS
J. HUMAN BIOBANKING APPLICATIONS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
5. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
6. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
EUROPE
7. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
8. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF EUROPEAN MARKET VALUE - (2017-2020)
ASIA-PACIFIC
9. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
10. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
REST OF WORLD
11. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
12. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF REST OF WORLD MARKET VALUE - (2017-2020)
K. HUMAN BIOBANKING ADVANCED APPLICATIONS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
13. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
14. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
EUROPE
15. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
16. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF EUROPEAN MARKET VALUE - (2017-2020)
ASIA-PACIFIC
17. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
18. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
REST OF WORLD
19. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
20. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF REST OF WORLD MARKET VALUE - (2017-2020)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report